28 April 2020

Dr. Kongkrapan Intarajang, CEO of GC, together with his executive team, present CoviClear, or the silver nanoparticle disinfection unit to help reduce the risk of COVID-19 transmission to Chulalongkorn Hospital, the Thai Red Cross Society

Share:

Dr. Kongkrapan Intarajang, Chief Executive Officer of GC, and his executive team presented CoviClear or the silver nanoparticle disinfection unit, which is designed to help lower the risk of contracting COVID-19 along with raw materials in producing two types of disinfectant liquid namely; triethanolamine (TEA) for which GC is the only manufacturer in Thailand, and Pharmaceutical-grade glycerine for use in CoviClear to Chulalongkorn Hospital, the Thai Red Cross Society in which the donation was received by Prof. Dr. Suttipong Wacharasindhu, Dean of the Faculty of Medicine, Chulalongkorn University, Assoc. Prof. Dr. Chanchai Sittipunt, Associate Dean for Planning and Development Department, and Asst. Prof. Dr. Nakarin Sirisabya, Assistant Dean for Planning and Development Department, Faculty of Medicine, Chulalongkorn University.

CoviClear is an innovation developed by GC that increases the disinfection and prevention of germs by releasing silver nanoparticles through a micron-sized nozzle in the form of a vapor. The vapor pairs the silver nanoparticles with viruses, bacteria and other diseases which a person carries, including on their clothing, killing them on contact without causing any harm.

News

News
10 December 2020
Carbon Disclosure Project Recognizes GC with a Prestigious “A” Score for Sustainability as the Company Strives to Retain its Leadership Globally
Read More
News
17 September 2020
GC Shares Best Practices to Turn Crisis into Opportunity at the TMA’s Sustainability Forum
Read More
News
17 July 2020
GC joins together with entrepreneurs and designers to launch ECO-Design products from the Upcycling Upstyling project [Thailand Property Today]
Read More